Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,751 · see citing works

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

Marzo, V. D., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,585 · see citing works

A method for measurement of analgesic activity on inflamed tissue.

Randall, L. O., & Selitto, J. J. (1957) · PubMed · Cited by 1,568 · see citing works

Manual of pharmacologic calculations with computer programs

(1988) · International Journal of Biochemistry · doi:10.1016/0020-711x(88)90084-5 · Cited by 1,458 · see citing works

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response.

Dahlén, S., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. O. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019 · see citing works

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 705 · see citing works

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Showalter, V. M., Compton, D. M., Martin, B. R., & Abood, M. E. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 572 · see citing works

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Compton, D. M., Rice, K. C., Costa, B., Razdan, R. K., Melvin, L. S., Johnson, M. R., & Martin, B. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38122-x · Cited by 461 · see citing works

Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding

Iadarola, M. J., Brady, L. S., Draisci, G., & Dubner, R. A. (1988) · Pain · doi:10.1016/0304-3959(88)90141-8 · Cited by 437 · see citing works

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

Smith, P. B., Compton, D. M., Welch, S. P., Razdan, R. K., Mechoulam, R., & Martin, B. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22356-4 · Cited by 394 · see citing works

Structure-activity relationships in cannabinoids.

Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 373 · see citing works

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

Compton, D. M., Aceto, M. D. G., Lowe, J. A., III, & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12911-x · Cited by 357 · see citing works

N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

Mazzari, S., Canella, R., Petrelli, L., Marcolongo, G., & Leon, A. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00015-5 · Cited by 334 · see citing works

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

Herzberg, U., Eliav, E., Bennett, G. J., & Kopin, I. J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13308-5 · Cited by 307 · see citing works

Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.

Lichtman, A. H., Cook, S. A., & Martin, B. R. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12310-0 · Cited by 261 · see citing works

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.

Devane, W. A., & Axelrod, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6698 · Cited by 220 · see citing works

Antinociceptive effects of μ- and κ-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

Stein, C., Millan, M. J., Yassouridis, A., & Herz, A. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90511-0 · Cited by 211 · see citing works

Adjuvant-induced arthritis in rats: A possible animal model of chronic pain

Costa, M. D. C., Sutter, P. D., Gybels, J., & Hees, J. V. (1981) · Pain · doi:10.1016/0304-3959(81)90193-7 · Cited by 208 · see citing works

Enzymatic Synthesis of Anandamide, an Endogenous Cannabinoid Receptor Ligand, through N-Acylphosphatidylethanolamine Pathway in Testis: Involvement of Ca2+-Dependent Transacylase and Phosphodiesterase Activities

Sugiura, T., Kondo, S., Sukagawa, A., Tonegawa, T., Nakane, S., Yamashita, A., & Waku, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0020 · Cited by 195 · see citing works

Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat

Millan, M. J., Członkowski, A., MORRIS, B. J., Stein, C., Arendt, R., Huber, A., Höllt, V., & Herz, A. (1988) · Pain · doi:10.1016/0304-3959(88)90140-6 · Cited by 193 · see citing works

Opioid Peptide Processing and Receptor Selectivity

Höllt, V. (1986) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.26.040186.000423 · Cited by 189 · see citing works

Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat

Colpaert, F. C., Meert, T. F., Witte, P. D., & Schmitt, P. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90402-7 · Cited by 164 · see citing works

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00952-1 · Cited by 150 · see citing works

Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

Welch, S. P., Thomas, C., & Patrick, G. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24328-2 · Cited by 124 · see citing works

The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

Pugh, G., Smith, P. B., Dombrowski, D. S., & Welch, S. P. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21168-5 · Cited by 123 · see citing works

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

Wiley, J. L., Barrett, R. L., Lowe, J. A., III, Balster, R. L., & Martin, B. R. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00027-4 · Cited by 122 · see citing works

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2

Hohmann, A. G., Martin, W. J., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00196-d · Cited by 121 · see citing works

Anti-edema and analgesic properties of delta9-tetrahydrocannabinol (THC).

Sofia, R. D., Nalepa, S. D., Harakal, J. J., & Vassar, H. B. (1973) · PubMed · Cited by 116 · see citing works

The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor.

Kruszka, K. K., & Gross, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36624-3 · Cited by 115 · see citing works

Cannabinoid-induced antinociception is mediated by a spinalα2-noradrenergic mechanism

Lichtman, A. H., & Martin, B. R. (1991) · Brain Research · doi:10.1016/0006-8993(91)90017-p · Cited by 114 · see citing works

Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord

Nahin, R. L., Hylden, J. L. K., Iadarola, M. J., & Dubner, R. A. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90386-8 · Cited by 99 · see citing works

The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat

Grubb, B. D., Birrell, G. J., McQueen, D. S., & Iggo, A. (1991) · Experimental Brain Research · doi:10.1007/bf00231460 · Cited by 99 · see citing works

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal slice

Collins, D. R., Pertwee, R. G., & Davies, S. N. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15889.x · Cited by 92 · see citing works

Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.

Welch, S. P. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38173-5 · Cited by 81 · see citing works

Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.

Welch, S. P., Dunlow, L. D., Patrick, G., & Razdan, R. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09617-x · Cited by 79 · see citing works

Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.

Fride, E., Barg, J., Levy, R., Saya, D., Heldman, E., Mechoulam, R., & Vogel, Z. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24465-2 · Cited by 75 · see citing works

Pharmacological and behavioral evaluation of alkylated anandamide analogs

Adams, I. B., Ryan, W. J., Singer, M., Razdan, R. K., Compton, D. M., & Martin, B. R. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00187-b · Cited by 70 · see citing works

Anandamides: tolerance and cross-tolerance toΔ9-tetrahydrocannabinol

Fride, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00790-w · Cited by 67 · see citing works

Morphine self-administration in the rat during adjuvant-induced arthritis

Lyness, W. H., Smith, F. L., Heavner, J. E., Iacono, C. U., & Garvin, R. D. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90062-3 · Cited by 66 · see citing works

Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.

Thomas, B. F., Wei, X., & Martin, B. R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10481-3 · Cited by 62 · see citing works

Characterization of anandamide-induced tolerance: comparison to Δ9-THC-induced interactions with dynorphinergic systems

Welch, S. P. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01342-2 · Cited by 57 · see citing works

Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats—A release and in situ hybridization study

Przewłocka, B., Lasoń, W., & Przewłocki, R. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90020-3 · Cited by 51 · see citing works

Antisense oligodeoxynucleotides to the κ-1 receptor block the antinociceptive effects of Δ9-THC in the spinal cord

Pugh, G., Abood, M. E., & Welch, S. P. (1995) · Brain Research · doi:10.1016/0006-8993(95)00560-d · Cited by 33 · see citing works

Formation of [Leu5]Enkephalin from Dynorphin A(1–8) by Rat Central Nervous Tissue In Vitro

Dixon, D. M., & Traynor, J. R. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb01972.x · Cited by 25 · see citing works

Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH)

Welch, S. P. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90245-3 · Cited by 21 · see citing works

The anti-inflammatory effects of LY178002 and LY256548

Panetta, J. A., Benslay, D. N., Phillips, M. L., Towner, R. D., Bertsch, B., Wang, L., & Ho, P. P. K. (1989) · Inflammation Research · doi:10.1007/bf01972804 · Cited by 9 · see citing works

Assessment of plasma leukotriene and prostaglandin levels during adjuvant arthritis and kaolin-induced paw oedema in rats.

Melli, M. (1988) · PubMed · Cited by 9 · see citing works

Anti-inflammatory effects of LY221068 and LY269415

Panetta, J. A., Benslay, D. N., SHADLE, J. K., Towner, R. D., & Ho, P. P. K. (1991) · Inflammation Research · doi:10.1007/bf01993249 · Cited by 5 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

The effects of cannabinoids on the brain

Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 805 · see citing works

Cannabinoid receptors and pain

Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741 · see citing works

Stress-induced analgesia

Butler, R. K., & Finn, D. P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.003 · Cited by 716 · see citing works

The Endocannabinoid System and Pain

Guindon, J., & Hohmann, A. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824660 · Cited by 476 · see citing works

Pharmacological and biochemical interactions between opioids and cannabinoids

Manzanares, J., Corchero, J., Romero, J., Fernández‐Ruíz, J., Ramos, J. A., & Fuentes, J. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01339-5 · Cited by 391 · see citing works

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L., & James, I. (2001) · Pain · doi:10.1016/s0304-3959(00)00474-7 · Cited by 379 · see citing works

Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

Richardson, D., Pearson, R. G., Kurian, N., Latif, M. L., Garle, M. J., Barrett, D. A., Kendall, D. A., Scammell, B. E., Reeve, A. J., & Chapman, V. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2401 · Cited by 303 · see citing works

Direct inhibition of T‐type calcium channels by the endogenous cannabinoid anandamide

Chemin, J., Monteil, A., Perez‐Reyes, E., Nargeot, J., & Lory, P. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7033 · Cited by 299 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia

Lichtman, A. H., Shelton, C. C., Advani, T., & Cravatt, B. F. (2004) · Pain · doi:10.1016/j.pain.2004.01.022 · Cited by 301 · see citing works

Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes

Manzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287 · see citing works

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models

Jayamanne, A., Greenwood, R., Mitchell, V. A., Aslan, S., Piomelli, D., & Vaughan, C. W. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706510 · Cited by 287 · see citing works

Motivational Effects of Cannabinoids Are Mediated by μ-Opioid and κ-Opioid Receptors

Ghozland, S. G., Matthes, H. W. D., Simonin, F., Filliol, D., Kieffer, B. L., & Maldonado, R. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-03-01146.2002 · Cited by 263 · see citing works

Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?

Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 256 · see citing works

Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers

Wallace, M. S., Schulteis, G., Atkinson, J. H., Wolfson, T. J., Lazzaretto, D., Bentley, H. A., Gouaux, B. D., & ABRAMSON, I. S. (2007) · Anesthesiology · doi:10.1097/01.anes.0000286986.92475.b7 · Cited by 250 · see citing works

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 256 · see citing works

Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist

Gallate, J. E., Saharov, T., Mallet, P. E., & McGregor, I. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00170-3 · Cited by 235 · see citing works

Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects

Wallace, M. J., Wiley, J. L., Martin, B. R., & DeLorenzo, R. J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01243-2 · Cited by 227 · see citing works

Targeting CB2 receptors and the endocannabinoid system for the treatment of pain

Anand, P., Whiteside, G. T., Fowler, C. J., & Hohmann, A. G. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.003 · Cited by 217 · see citing works

The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions

Naef, M., Curatolo, M., Petersen-Felix, S., Arendt-Nielsen, L., Zbinden, A., & Brenneisen, R. (2003) · Pain · doi:10.1016/s0304-3959(03)00163-5 · Cited by 209 · see citing works

Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development

Pertwee, R. G. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.7.1553 · Cited by 228 · see citing works

Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

Baron, E. P. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12570 · Cited by 205 · see citing works

The endogenous cannabinoid system and its role in nociceptive behavior

Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203 · see citing works

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

Rice, A. S. C., Farquhar-Smith, W. P., & Nagy, I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0362 · Cited by 183 · see citing works

Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 182 · see citing works

Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders

PETROCELLIS, L. D., Melck, D. J., Bisogno, T., & Marzo, V. D. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00196-1 · Cited by 174 · see citing works

Synergistic interactions of endogenous opioids and cannabinoid systems

Welch, S. P., & Eads, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01908-3 · Cited by 169 · see citing works

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation

Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 162 · see citing works

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 159 · see citing works

Sex differences in antinociceptive and motoric effects of cannabinoids.

Tseng, A. H., & Craft, R. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01267-5 · Cited by 156 · see citing works

Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord

Morisset, V., & Urbán, L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.40 · Cited by 152 · see citing works

A role for endocannabinoids in indomethacin-induced spinal antinociception

Gühring, H., Hamza, M., Sergejeva, M., Ateş, M., Kotalla, C., Ledent, C. A., & Brune, K. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02485-8 · Cited by 121 · see citing works

Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord

Salio, C., Fischer, J., Franzoni, M. F., & Conrath, M. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00584-x · Cited by 120 · see citing works

Antinociceptive, subjective and behavioral effects of smoked marijuana in humans

Greenwald, M. K., & Stitzer, M. L. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00128-3 · Cited by 119 · see citing works

A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats

Pascual, D., Goicoechea, C., Suardíaz, M., & Martín, M. I. (2005) · Pain · doi:10.1016/j.pain.2005.07.008 · Cited by 117 · see citing works

Cannabinoid Transmission and Pain Perception

Martin, B. R., & Lichtman, A. H. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0218 · Cited by 117 · see citing works

A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain

Kehl, L. J., Hamamoto, D. T., Wacnik, P. W., Croft, D. L., Norsted, B. D., Wilcox, G. L., & Simone, D. A. (2003) · Pain · doi:10.1016/s0304-3959(02)00450-5 · Cited by 115 · see citing works

Cannabinoids modulate pain by multiple mechanisms of action

Richardson, J. D. (2000) · The Journal of Pain · doi:10.1016/s1526-5900(00)90082-8 · Cited by 109 · see citing works

Cannabinoids and Pain

Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108 · see citing works

Metabotropic and NMDA glutamate receptors participate in the cannabinoid-induced antinociception

Palazzo, E., Marabese, I., de Novellis, V., Oliva, P., Rossi, F., Berrino, L., Rossi, F., & Maione, S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00160-x · Cited by 106 · see citing works

Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine

Roberts, J. D., Gennings, C., & Shih, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.11.036 · Cited by 103 · see citing works

Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat

Beaulieu, P., Bisogno, T., Punwar, S., Farquhar-Smith, W. P., Ambrosino, G., Marzo, V. D., & Rice, A. S. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00226-0 · Cited by 101 · see citing works

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55

Alba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 94 · see citing works

Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

Karst, M., Wippermann, S., & Ahrens, J. (2010) · Drugs · doi:10.2165/11585260-000000000-00000 · Cited by 91 · see citing works

Interaction of the cannabinoid and opioid systems in the modulation of nociception

Welch, S. P. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782794 · Cited by 92 · see citing works

Core Outcome Measures in Preclinical Assessment of Candidate Analgesics

Negus, S. S. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017210 · Cited by 89 · see citing works

Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat

Helyes, Z., Németh, J., Thán, M., Bölcskei, K., Pintér, E., & Szolcsányi, J. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00651-9 · Cited by 85 · see citing works

Possible mechanisms of cannabinoid-induced antinociception in the spinal cord

Morisset, V., Ahluwalia, J. P., Nagy, I., & Urbán, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01309-7 · Cited by 86 · see citing works

Cannabidiol-Δ 9 -tetrahydrocannabinol interactions on acute pain and locomotor activity

Britch, S. C., Wiley, J. L., Yu, Z., Clowers, B. H., & Craft, R. M. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.01.046 · Cited by 83 · see citing works

Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat

Cox, M. L., Haller, V. L., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.010 · Cited by 78 · see citing works

Dynamic changes to the endocannabinoid system in models of chronic pain

Sagar, D. R., Burston, J. J., Woodhams, S. G., & Chapman, V. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0390 · Cited by 76 · see citing works

Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain

Schuelert, N., Zhang, C., Mogg, A. J., Broad, L. M., Hepburn, D. L., Nisenbaum, E. S., Johnson, M. P., & McDougall, J. J. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.09.005 · Cited by 77 · see citing works

Actions of N-Arachidonyl-Glycine in a Rat Inflammatory Pain Model

Succar, R., Mitchell, V. A., & Vaughan, C. W. (2007) · Molecular Pain · doi:10.1186/1744-8069-3-24 · Cited by 77 · see citing works

( R )-Methanandamide and Δ 9 -THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide

Järbe, T. U. C., Lamb, R. J., Lin, S., & Makriyannis, A. (2001) · Psychopharmacology · doi:10.1007/s002130100730 · Cited by 77 · see citing works

Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice

Monory, K., Tzavara, E. T., Lexime, J., Ledent, C. A., Parmentier, M., Borsodi, A. D., & Hanoune, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6635 · Cited by 75 · see citing works

Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate

La Porta, C., Bura, S. A., Aracil-Fernández, A., Manzanares, J., & Maldonado, R. (2013) · Pain · doi:10.1016/j.pain.2012.10.009 · Cited by 75 · see citing works

Biochemical and Biological Properties of 4-(3-phenyl-[1,2,4] thiadiazol-5-yl)-piperazine-1-carboxylic acid phenylamide, a Mechanism-Based Inhibitor of Fatty Acid Amide Hydrolase

Karbarz, M. J., Luo, L., Chang, L., Tham, C.-S., Palmer, J. A., Wilson, S. J., Wennerholm, M. L., Brown, S. M., Scott, B. P., Apodaca, R. L., et al. (2009) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e31818c7cbd · Cited by 74 · see citing works

The role of TRPV1 receptors in the antinociceptive effect of anandamide at spinal level

Horváth, G., Kékesi, G., Nagy, E., & Benedek, G. (2007) · Pain · doi:10.1016/j.pain.2007.04.032 · Cited by 74 · see citing works

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide1Published on the World Wide Web on 18 January 2000.1

Houser, S. J., Eads, M., Embrey, J. P., & Welch, S. P. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01981-8 · Cited by 73 · see citing works

Cannabis and Cannabinoids: Pharmacology and Rationale for Clinical Use

Pertwee, R. G. (1999) · Complementary Medicine Research · doi:10.1159/000057150 · Cited by 72 · see citing works

Cannabinoids as potential new analgesics

Fuentes, J., Ruiz‐Gayo, M., Manzanares, J., Vela, G., Reche, I., & Corchero, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00290-8 · Cited by 72 · see citing works

The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain

Liang, Y.-C., Huang, C.-C., & Hsu, K.-S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.019 · Cited by 68 · see citing works

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model

Anderson, W. B., Gould, M. J., Torres, R. D., Mitchell, V. A., & Vaughan, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.018 · Cited by 67 · see citing works

Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice

Castañé, A., Robledo, P., Matifas, A., Kieffer, B. L., & Maldonado, R. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02409.x · Cited by 67 · see citing works

The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy

Wallace, V. C. J., Segerdahl, A. R., Lambert, D. M., Vandevoorde, S., Blackbeard, J., Pheby, T., Hasnie, F., & Rice, A. S. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707326 · Cited by 66 · see citing works

The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and Ketorolac

Ulugöl, A., Özyiğit, F., Yeşilyurt, Ö., & Dogrul, A. B. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000194587.94260.1d · Cited by 66 · see citing works

Cannabimimetic fatty acid derivatives in cancer and inflammation

Marzo, V. D., Melck, D. J., PETROCELLIS, L. D., & Bisogno, T. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00054-x · Cited by 66 · see citing works

Effects of Smoked Cannabis and Oral δ9-Tetrahydrocannabinol on Nausea and Emesis After Cancer Chemotherapy

Musty, R. E., & Rossi, R. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n01_03 · Cited by 64 · see citing works

3-[2-Cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A Novel Cannabinoid CB1/CB2 Receptor Partial Agonist with Antihyperalgesic and Antiallodynic Effects

De Vry, J., Denzer, D., Reissmueller, E., Eijckenboom, M., Heil, M., Meier, H., & Mauler, F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062836 · Cited by 63 · see citing works

Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice

Valverde, O., Karsak, M., & Zimmer, A. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_4 · Cited by 61 · see citing works

A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors

Xiong, W., Wu, X., Lovinger, D. M., & Li, Z. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6347-11.2012 · Cited by 62 · see citing works

The endocannabinoid system and its therapeutic implications in rheumatoid arthritis

Gui, H., Tong, Q., Qu, W., Mao, C.-M., & Dai, S. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.03.006 · Cited by 54 · see citing works

Blockade of central cyclooxygenase (COX) pathways enhances the cannabinoid-induced antinociceptive effects on inflammatory temporomandibular joint (TMJ) nociception

Ahn, D. K., Choi, H. S., Yeo, S. P., Woo, Y. W., Lee, M. K., Yang, G. Y., Jeon, H., Park, J. S., & Mokha, S. S. (2007) · Pain · doi:10.1016/j.pain.2007.01.015 · Cited by 51 · see citing works

Cannabis and Cannabinoids in Reproduction and Fertility: Where We Stand

Fonseca, B. M., & Rebelo, I. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00588-1 · Cited by 48 · see citing works

The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor

Cox, M. L., Haller, V. L., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.024 · Cited by 48 · see citing works

Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2‐arachidonoyl‐glycerol and its congeners in human myeloid leukocytes

Turcotte, C., Archambault, A., Dumais, É., Martin, C., Blanchet, M., Bissonnette, É. Y., Ohashi, N., Yamamoto, K., Itoh, T., Laviolette, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902916r · Cited by 46 · see citing works

Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase

Haller, V. L., Stevens, D. L., & Welch, S. P. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.08.005 · Cited by 45 · see citing works

Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models

Mitchell, V. A., Greenwood, R., Jayamanne, A., & Vaughan, C. W. (2007) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04692.x · Cited by 43 · see citing works

The cannabinoid agonist WIN 55, 212-2 increases nociception threshold in cholestatic rats: implications for the treatment of the pruritus of cholestasis

Gingold, A. R., & Bergasa, N. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00668-4 · Cited by 43 · see citing works

Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors

Wise, L. E., Shelton, C. C., Cravatt, B. F., Martin, B. R., & Lichtman, A. H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.002 · Cited by 40 · see citing works

A data science approach to candidate gene selection of pain regarded as a process of learning and neural plasticity

Ultsch, A., Kringel, D., Kalso, E. A., Mogil, J. S., & Lötsch, J. (2016) · Pain · doi:10.1097/j.pain.0000000000000694 · Cited by 38 · see citing works

Peripheral analgesia: Hitting pain where it hurts

McDougall, J. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.011 · Cited by 37 · see citing works

Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain

Liu, C., & Walker, J. M. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00498.2006 · Cited by 37 · see citing works

Interactions between Δ9-tetrahydrocannabinol and heroin

Li, J., Koek, W., & France, C. P. (2012) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835a3907 · Cited by 36 · see citing works

Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study

Valastro, C., Campanile, D., Marinaro, M., Franchini, D., Piscitelli, F., Verde, R., Marzo, V. D., & Bello, A. D. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1245-7 · Cited by 36 · see citing works

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat

Cox, M. L., & Welch, S. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.022 · Cited by 35 · see citing works

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

Järbe, T. U. C., DiPatrizio, N. V., Li, C., & Makriyannis, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00168-0 · Cited by 35 · see citing works

Cannabinoids and Reproduction: A Lasting and Intriguing History

Cacciola, G., Chianese, R., Chioccarelli, T., Ciaramella, V., Fasano, S., Pierantoni, R., Meccariello, R., & Cobellis, G. (2010) · Pharmaceuticals · doi:10.3390/ph3103275 · Cited by 33 · see citing works

Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain

Hama (2009) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2008.04.0049 · Cited by 32 · see citing works

Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain

Mitchell, V. A., Aslan, S. C., Safaei, R., & Vaughan, C. W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.03.019 · Cited by 31 · see citing works

Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain

Bagüés, A., Martı́n, M. I., & Sánchez-Robles, E. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.016 · Cited by 29 · see citing works

Cannabinoids in the treatment of rheumatic diseases: Pros and cons

Sarzi‐Puttini, P., Ablin, J. N., Trabelsi, A., Fitzcharles, M., Marotto, D., & Häuser, W. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102409 · Cited by 30 · see citing works

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats

Seol, T., Lee, W., Park, S., Kim, K. N., Kim, T. Y., Oh, Y. N., & Jun, J. H. (2017) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2017.70.5.561 · Cited by 28 · see citing works

Pro-algesic versus analgesic actions of immune cells

Rittner, H. L., Brack, A., & Stein, C. (2003) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-200310000-00014 · Cited by 28 · see citing works

Anandamide inhibits the DOI-induced head-twitch response in mice

Egashira, N., Mishima, K., Uchida, T., Hasebe, N., Nagai, H., Mizuki, A., Iwasaki, K., ISHII, H., Nishimura, R., Shoyama, Y., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1611-y · Cited by 27 · see citing works

Focus on the Three Key Enzymes Hydrolysing Endocannabinoids as New Drug Targets

Vandevoorde, S., & Lambert, D. M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054546914 · Cited by 26 · see citing works

Ultra-low dose naltrexone enhances cannabinoid-induced antinociception

Paquette, J. J., & Olmstead, M. C. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00001 · Cited by 26 · see citing works

Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists

Bosier, B., Sarre, S., Smolders, I. J., Michotte, Y. M., Hermans, E., & Lambert, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.005 · Cited by 24 · see citing works

Cannabis: Time for Scientific Evaluation of This Ancient Remedy?

Sharpe, P., & Smith, G. (2000) · Anesthesia & Analgesia · doi:10.1097/00000539-200002000-00001 · Cited by 21 · see citing works

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat

Cox, M. L., & Welch, S. P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.022 · Cited by 35 · see citing works

The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor

Cox, M. L., Haller, V. L., & Welch, S. P. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.024 · Cited by 48 · see citing works

Nondeterministic individual responses to receptor selective opioid analgesics

Lipkowski, A. W., SILBERT, B. S., Cepeda, M. S., Osgood, P. F., SZYFELBEIN, S. K., & Carr, D. B. (1990) · Pain · doi:10.1016/0304-3959(90)92647-9 · Cited by 1 · see citing works

Anxiety does not affect the antinociceptive effect of Δ9-THC in mice: participation of cannabinoid and opioid receptors

Takahashi, R. N., Ramos, G. A., & Assini, F. L. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00151-5 · Cited by 6 · see citing works

Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.

Welch, S. P., Dunlow, L. D., Patrick, G., & Razdan, R. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09617-x · Cited by 79 · see citing works